EN
EN
Drug category

InnoStar provides you with one-stop technical services

covering the life cycle of new drug research and development, PCC-IND-NDA


Research services
Drug categories
SERVICES
One-stop technology service
platform covering the life cycle of new drug R&D (PCC-IND-NDA)
R&D service
Service benefits

With leading industrial international service capabilities and in line with international standards, InnoStar provides global pharmaceutical enterprises and research institutions with comprehensive one-stop drug research and development services that meet domestic and international registration standards. As of Dec 31, 2025, We have achieved Global NDA/BLA Approvals: 35 and Global IND Approvals: 830+. InnoStar has enabled more than 140 projects IND approved by various national authorities including the United States, the European Union, South Korea, Japan and Australia, and enabled 3 innovative drugs NDA/BLA approved by FDA.

Service benefits

Copyright © 2017-2021©Shanghai InnoStar Bio-tech Co., Ltd. All Rights Reserved. Created By VPABrand.com

沪ICP备16028608号-2 沪公网安备 31011502016605号